114 related articles for article (PubMed ID: 38245918)
1. Longitudinal changes of angiogenic factors as a potential predictive tool in women with suspected preeclampsia.
Montenegro-Martínez J; Camacho-Carrasco A; Nuñez-Jurado D; Beltrán-Romero LM; Fatela-Cantillo D
Pregnancy Hypertens; 2024 Mar; 35():66-72. PubMed ID: 38245918
[TBL] [Abstract][Full Text] [Related]
2. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
3. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Prognostic Value of the sFlt-1/PlGF Ratio in Early-Onset Preeclampsia.
Tasta O; Parant O; Hamdi SM; Allouche M; Vayssiere C; Guerby P
Am J Perinatol; 2021 Aug; 38(S 01):e292-e298. PubMed ID: 32446261
[TBL] [Abstract][Full Text] [Related]
5. Serum sFlt-1/PlGF ratio has better diagnostic ability in early- compared to late-onset pre-eclampsia.
Chuah TT; Tey WS; Ng MJ; Tan ETH; Chern B; Tan KH
J Perinat Med; 2018 Dec; 47(1):35-40. PubMed ID: 29708884
[TBL] [Abstract][Full Text] [Related]
6. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
[TBL] [Abstract][Full Text] [Related]
7. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
[TBL] [Abstract][Full Text] [Related]
8. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis].
Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M
Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
[TBL] [Abstract][Full Text] [Related]
10. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
[TBL] [Abstract][Full Text] [Related]
11. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510
[TBL] [Abstract][Full Text] [Related]
12. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients.
Zhu X; Chen L; Li R
Clin Exp Hypertens; 2020 Oct; 42(7):601-607. PubMed ID: 32338084
[TBL] [Abstract][Full Text] [Related]
13. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
Birdir C; Droste L; Fox L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
Pregnancy Hypertens; 2018 Apr; 12():124-128. PubMed ID: 29674192
[TBL] [Abstract][Full Text] [Related]
16. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
17. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
[TBL] [Abstract][Full Text] [Related]
19. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study.
Peguero A; Fernandez-Blanco L; Mazarico E; Benitez L; Gonzalez A; Youssef L; Crispi F; Hernandez S; Figueras F
BJOG; 2021 Jan; 128(2):158-165. PubMed ID: 32593222
[TBL] [Abstract][Full Text] [Related]
20. The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16-20 Weeks Gestation.
Benovská M; Opluštilová A; Pinkavová J; Hodická Z; Cermáková Z
Lab Med; 2018 Mar; 49(2):112-117. PubMed ID: 29267975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
